Table 1.
General characteristics of the study group.
| Factor | Study Group (n = 69) | |
|---|---|---|
| Gender | Male | 59 (85.51%) |
| Female | 10 (14.49%) | |
| Age [years] | Mean ± standard deviation, median (range) |
63.5 ± 9.3, 63 (42–87) |
| ≥65 | 29 (42.03%) | |
| <65 | 40 (57.97%) | |
| Histopathological diagnosis | Squamous cell carcinoma | 64 (92.75%) |
| Other | 5 (7.25%) | |
| Tumor location | Oropharyngeal | 29 (42.03%) |
| Larynx | 36 (52.17%) | |
| Others | 4 (5.80%) | |
| T stage | T1 | 2 (2.90%) |
| T2 | 12 (17.39%) | |
| T3 | 22 (31.88%) | |
| T4 | 33 (47.83%) | |
| N stage | N0 | 23 (33.33%) |
| N1 | 8 (11.59%) | |
| N2 | 32 (46.38%) | |
| N3 | 6 (8.70%) | |
| M stage | M0 | 68 (98.55%) |
| M1 | 1 (1.45%) | |
| Disease stage | III | 20 (28.98%) |
| IVA | 39 (56.52%) | |
| IVB | 4 (5.80%) | |
| IVC | 6 (8.70%) | |
| Performance status (PS) | ≤1 | 59 (85.51%) |
| >1 | 10 (14.49%) | |
| Type of treatment | Surgery + RT | 29 (42.03%) |
| Surgery + C-RT | 18 (26.09%) | |
| RTH alone | 9 (13.04%) | |
| Induction CTH +RT | 3 (4.35%) | |
| C-RT | 6 (8.69%) | |
| Induction CTH +C-RT | 3 (4.35%) | |
| Induction CTH + Surgery + C-RT | 1 (1.45%) | |
| Alcohol consumption | Yes | 29 (42.03%) |
| No | 40 (57.97%) | |
| Smoking status | Smoker | 51 (73.91%) |
| Non-smoker | 18 (26.09%) | |
| Current smoker | 47 (92.16%) | |
| Former smoker | 4 (7.84%) | |
| Smoking during treatment | 43 (91.49%) | |
| Does not smoke during treatment | 4 (8.51%) | |
| Parenteral nutrition | Yes | 8 (11.59%) |
| No | 61 (88.41%) | |
| Weight [kg] | Mean ± standard deviation, median (range) |
65.2 ± 11.4, 66 (43–9) |
| BMI [kg/m2] | Mean ± standard deviation, median (range) |
23 ± 4,3, 22.8 (14.5–34.4) |
| SGA | A | 15 (21.74%) |
| B | 32 (46.38%) | |
| C | 22 (31.88%) | |
| NRS | 2 | 47 (68.12%) |
| 3 | 19 (27.54%) | |
| 4 | 2 (2.90%) | |
| 5 | 1 (1.44%) | |
| CWL | Yes | 25 (36.23%) |
| No | 44 (63.77%) | |